Evidence map›Paper›PMID 38589946›Full record

ArticleStem cell research & therapy2024

Oral ulcer treatment using human tonsil-derived mesenchymal stem cells encapsulated in trimethyl chitosan hydrogel: an animal model study.

Hyun Seok Ryu, Celine Abueva, Andrew Padalhin, So Young Park, Seung Hyeon Yoo, Hwee Hyon Seo, Phil-Sang Chung, Seung Hoon Woo

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Mesenchymal Stem Cell Therapy for Oral Lichen Planus: A Paradigm Shift from Palliation to Regeneration.International journal of hematology-oncology and stem cell research · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hyun Seok RyuBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea.
Celine AbuevaBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea.
Andrew PadalhinBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea.
So Young ParkBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea.
Seung Hyeon YooSchool of Medical Laser, Dankook University, Cheonan, Republic of Korea.
Hwee Hyon SeoSchool of Medical Laser, Dankook University, Cheonan, Republic of Korea.
Phil-Sang ChungBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea.
Seung Hoon WooBeckman Laser Institute Korea, Dankook University College of Medicine, Cheonan, Republic of Korea. lesaby@hanmail.net.ORCID 0000-0001-7560-1140
Dankook University · KR

Funding

Korea Health Industry Development Institute HI20C2088Korea Medical Device Development Fund KMDF_PR_20200901_0027-03National Research Foundation of Korea NRF-2020R1A6A1A03043283National Research Foundation of Korea NRF-2023K1A4A3A02057280National Research Foundation of Korea RS-2023-00247651
6 · The paper itself

Abstract

backgroundOral ulcers are a common side effect of chemotherapy and affect patients' quality of life. While stem cell transplantation is a potential treatment for oral ulcers, its efficacy is limited as the stem cells tend to remain in the affected area for a short time. This study aims to develop a treatment for oral ulcers by using trimethyl chitosan (TMC) hydrogel with human tonsil-derived stem cells (hTMSCs) to increase the therapeutic effect of stem cells and investigate their effectiveness.

methodsAnimals were divided into four experimental groups: Control, TMC hydrogel, hTMSCs, and hTMSCs loaded in TMC hydrogel (Hydrogel + hTMSCs) (each n = 8). Oral ulcers were chemically induced by anesthetizing the rats followed by injection of dilute acetic acid in the right buccal mucosa. After confirming the presence of oral ulcers in the animals, a single subcutaneous injection of 100 µL of each treatment was applied to the ulcer area. Histological analyses were performed to measure inflammatory cells, oral mucosal thickness, and fibrosis levels. The expression level of inflammatory cytokines was also measured using RT-PCR to gauge therapeutic the effect.

resultsThe ulcer size was significantly reduced in the TMC hydrogel + hTMSCs group compared to the control group. The stem cells in the tissue were only observed until Day 3 in the hTMSCs treated group, while the injected stem cells in the TMC Hydrogel + hTMSCs group were still present until day 7. Cytokine analysis related to the inflammatory response in the tissue confirmed that the TMC Hydrogel + hTMSCs treated group demonstrated superior wound healing compared to other experimental groups.

conclusionThis study has shown that the adhesion and viability of current stem cell therapies can be resolved by utilizing a hydrogel prepared with TMC and combining it with hTMSCs. The combined treatment can promote rapid healing of oral cavity wounds by enhancing anti-inflammatory effects and expediting wound healing. Therefore, hTMSC loaded in TMC hydrogel was the most effective wound-healing approach among all four treatment groups prolonging stem cell survival. However, further research is necessary to minimize the initial inflammatory response of biomaterials and assess the safety and long-term effects for potential clinical applications.

Indexed as

ChitosanMesenchymal Stem CellsOral UlcerAnimalsCytokinesHumansHydrogelsModels, AnimalPalatine TonsilQuality of LifeRatsUlcerChitosanCytokinesHydrogelsHydrogelOral ulcerTonsil-derived mesenchymal stem cellTrimethyl chitosan

Identifiers

PMID38589946
PMCPMC11003084
OpenAlexW4394582447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.